BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16644140)

  • 1. Statins and tissue mineralization: putative involvement of alkaline phosphatase.
    Negrão MR; Mota A; Azevedo I; Martins MJ
    Med Hypotheses; 2006; 67(3):524-8. PubMed ID: 16644140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins and bone metabolism.
    Horiuchi N; Maeda T
    Oral Dis; 2006 Mar; 12(2):85-101. PubMed ID: 16476028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Statins and osteoporosis].
    Svejda P
    Vnitr Lek; 2006 Dec; 52(12):1190-3. PubMed ID: 17299913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigations of statins in heart failure: inflammatory biomarkers and hormones.
    Khan BV; Rajagopalan S
    Heart Fail Clin; 2008 Apr; 4(2):171-6. PubMed ID: 18433697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin withdrawal: clinical implications and molecular mechanisms.
    Cubeddu LX; Seamon MJ
    Pharmacotherapy; 2006 Sep; 26(9):1288-96. PubMed ID: 16945051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of stroke and dementia by statin therapy: experimental and clinical evidence of their pleiotropic effects.
    Miida T; Takahashi A; Ikeuchi T
    Pharmacol Ther; 2007 Feb; 113(2):378-93. PubMed ID: 17113151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond lipid lowering: What have we learned about the benefits of statins from the acute coronary syndromes trials?
    Ray KK; Cannon CP; Ganz P
    Am J Cardiol; 2006 Dec; 98(11A):18P-25P. PubMed ID: 17126675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The acute (cerebro)vascular effects of statins.
    Prinz V; Endres M
    Anesth Analg; 2009 Aug; 109(2):572-84. PubMed ID: 19608834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Statins and their pleiotropic effects].
    Galus R; Zandecki Ł; Jóźwiak J; Włodarski K
    Pol Merkur Lekarski; 2008 Jun; 24(144):545-8. PubMed ID: 18702340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins in stroke prevention: what an internist should know.
    Castilla Guerra L; del Carmen Fernández Moreno M; López Chozas JM; Jiménez Hernández MD
    Eur J Intern Med; 2008 Jan; 19(1):8-14. PubMed ID: 18206595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of differences among statins and a comparison with antioxidant vitamins.
    Mason RP
    Am J Cardiol; 2006 Dec; 98(11A):34P-41P. PubMed ID: 17126678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of statin medications on perioperative and long-term outcomes following carotid endarterectomy or stenting.
    Perler BA
    Semin Vasc Surg; 2007 Dec; 20(4):252-8. PubMed ID: 18082842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of statins in heart failure.
    Gullestad L; Oie E; Ueland T; Yndestad A; Aukrust P
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():35-40. PubMed ID: 18001320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rate of bone mineralization in birds is directly related to alkaline phosphatase activity.
    Tilgar V; Kilgas P; Viitak A; Reynolds SJ
    Physiol Biochem Zool; 2008; 81(1):106-11. PubMed ID: 18040977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
    Robinson JG
    Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug insight: Immunomodulatory effects of statins--potential benefits for renal patients?
    Steffens S; Mach F
    Nat Clin Pract Nephrol; 2006 Jul; 2(7):378-87. PubMed ID: 16932466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug insight: statins for nonischemic heart failure--evidence and potential mechanisms.
    Lipinski MJ; Abbate A; Fuster V; Vetrovec GW
    Nat Clin Pract Cardiovasc Med; 2007 Apr; 4(4):196-205. PubMed ID: 17380165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins in the treatment of chronic heart failure: biological and clinical considerations.
    van der Harst P; Voors AA; van Gilst WH; Böhm M; van Veldhuisen DJ
    Cardiovasc Res; 2006 Aug; 71(3):443-54. PubMed ID: 16730683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin use and cancer risk: an epidemiologic review.
    Friis S; Olsen JH
    Cancer Invest; 2006; 24(4):413-24. PubMed ID: 16777695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleiotropic effects and cholesterol-lowering therapy.
    Shaw SM; Fildes JE; Yonan N; Williams SG
    Cardiology; 2009; 112(1):4-12. PubMed ID: 18577880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.